ReNu Energy (ASX:RNE) - CEO, Greg Watson
CEO, Greg Watson
Source: ReNu Energy
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • ReNu Energy (RNE) closes its share purchase plan (SPP), raising $1.25 million for its renewable and clean energy investments
  • About 13.85 million new shares will be issued at a price of 9 cents per share
  • About 3.46 million new options will be issued with an exercise price of 7 cents per share, expiring at the end of next year
  • The new shares will be issued today and begin trading on the ASX on Monday
  • Shares were trading flat today at 7.1 cents each at 1:48 pm.

ReNu Energy (RNE) closes its share purchase plan (SPP), raising $1.25 million for its renewable and clean energy investments.

About 13.85 million new shares will be issued at a price of 9 cents per share.

Eligible applicants will also receive one attaching option for every four shares subscribed.

About 3.46 million new options will be issued with an exercise price of 7 cents per share, expiring at the end of next year.

The SPP was announced in December following the company’s $2.38 million placement.

The funds will be used to advance the company’s green hydrogen projects following its completion of the acquisition of Countrywide Renewable Hydrogen.

It will also be used for other renewable and clean energy investments as well as to cover the costs associated with the offer.

The new shares will be issued today and begin trading on the ASX on Monday.

Shares were trading flat today at 7.1 cents each at 1:48 pm.

RNE by the numbers
More From The Market Online
Cambodia flag

The first IPO of 2026 has landed. It’s exploring for gold, but nobody’s paying attention

Spare a thought for Unity Metals (ASX:UM1), the first IPO of 2026 to hit the ASX boards trading –
Exit sign

Lynas Rare Earths’ CEO out the door even as 1Y returns up +110%

Lynas Rare Earths (ASX:LYC) has revealed to the market on Tuesday its CEO Amanda Lacaze is out the door
AI image of a lung cross section

4DX up another 15% on new demo delivery; now boasting $2.5B cap & no revenue

4DMedical has climbed to a lofty valuation just short of $4.80 on Wednesday, bringing the biotech…
Man holds Aus notes

4DMedical reportedly raising $150M at $3.80/sh; ASX 200 inclusion possible

4DMedical has startled some HotCopper forum users as it stages a $150 million capital raising at…